Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Lipocalin 2 is present in the EAE brain and is modulated by natalizumab.
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS.
Overcoming barriers in progressive multiple sclerosis research.
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Epigenetic changes in patients with multiple sclerosis.
Pregnancy outcomes in female patients and partners of male patients in the teriflunomide clinical development program.
Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks.
The AusD Study: A Population-based Study of the Determinants of Serum 25-Hydroxyvitamin D Concentration Across a Broad Latitude Range.
SMC Says Yes to Lemtrada(R)a- 1/4 (alemtuzumab) 12mg IV, a New Treatment for Adults with Active Relapsing Remitting-Multiple Sclerosis (RRMS)
The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis.
Motor skill learning requires active central myelination.
Laquinimod - New Promising Treatment for Multiple Sclerosis
MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8(+) T cells.
Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
Multiple sclerosis.
High dose thiamine improves fatigue in multiple sclerosis.
Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-beta-1b: a case report.
Identification of Selective Inhibitors of the Potassium Channel Kv1.1-1.2((3)) by High-Throughput Virtual Screening and Automated Patch Clamp.
First use of alemtuzumab in Balo's concentric sclerosis: a case report.
Metabolic features of the cell danger response.
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.

Pages